The Role of Infection in Interstitial Lung Diseases: A Review
- PMID: 28400116
- PMCID: PMC7094545
- DOI: 10.1016/j.chest.2017.03.033
The Role of Infection in Interstitial Lung Diseases: A Review
Abstract
Interstitial lung disease (ILD) comprises an array of heterogeneous parenchymal lung diseases that are associated with a spectrum of pathologic, radiologic, and clinical manifestations. There are ILDs with known causes and those that are idiopathic, making treatment strategies challenging. Prognosis can vary according to the type of ILD, but many exhibit gradual progression with an unpredictable clinical course in individual patients, as seen in idiopathic pulmonary fibrosis and the phenomenon of "acute exacerbation"(AE). Given the often poor prognosis of these patients, the search for a reversible cause of respiratory worsening remains paramount. Infections have been theorized to play a role in ILDs, both in the pathogenesis of ILD and as potential triggers of AE. Research efforts thus far have shown the highest association with viral pathogens; however, fungal and bacterial organisms have also been implicated. This review aims to summarize the current knowledge on the role of infections in the setting of ILD.
Keywords: infection; interstitial lung disease; pulmonary fibrosis.
Copyright © 2017 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.
Comment in
-
Potential Mechanisms of Microbial Pathogens in Idiopathic Interstitial Lung Disease.Chest. 2017 Oct;152(4):899-900. doi: 10.1016/j.chest.2017.05.024. Chest. 2017. PMID: 28991543 No abstract available.
-
Response.Chest. 2017 Oct;152(4):900. doi: 10.1016/j.chest.2017.05.022. Chest. 2017. PMID: 28991544 Free PMC article. No abstract available.
References
-
- American Thoracic Society, European Respiratory Society American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med. 2002;165(2):277–304. - PubMed
-
- Ryu J.H., Moua T., Daniels C.E. Idiopathic pulmonary fibrosis: evolving concepts. Mayo Clin Proc. 2014;89(8):1130–1142. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical